(S)-8-(3-chloro-4-fluorobenzyl)-2,3-dicyclopropyl-6-hydroxy-2,3,9,10-tetrahydroimidazo[5,1-a][2,6]naphthyridine-1,5,7(8H)-trione

ID: ALA4078272

PubChem CID: 117743977

Max Phase: Preclinical

Molecular Formula: C23H21ClFN3O4

Molecular Weight: 457.89

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1c2c(c3n(c(=O)c2O)[C@@H](C2CC2)N(C2CC2)C3=O)CCN1Cc1ccc(F)c(Cl)c1

Standard InChI:  InChI=1S/C23H21ClFN3O4/c24-15-9-11(1-6-16(15)25)10-26-8-7-14-17(21(26)30)19(29)23(32)28-18(14)22(31)27(13-4-5-13)20(28)12-2-3-12/h1,6,9,12-13,20,29H,2-5,7-8,10H2/t20-/m0/s1

Standard InChI Key:  STNHOJJHMDPOJN-FQEVSTJZSA-N

Molfile:  

     RDKit          2D

 32 37  0  0  0  0  0  0  0  0999 V2000
    1.7898   -3.8135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7887   -4.6331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4967   -5.0420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2064   -4.6326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2035   -3.8099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4949   -3.4047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9147   -5.0401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6218   -4.6304    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3246   -5.0412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3243   -3.4078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6131   -3.8157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3220   -5.8584    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.0325   -3.8174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0273   -4.6331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7300   -5.0435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4383   -4.6395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7258   -5.8607    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1446   -5.0504    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7362   -3.4140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4390   -3.8167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0392   -3.2727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7073   -2.5338    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9021   -2.6211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3533   -2.0156    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8391   -3.4401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4475   -3.9813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6148   -3.1814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0820   -3.4051    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.0806   -5.0411    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    8.1136   -1.8247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8163   -1.4153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1072   -1.0091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  8 11  1  0
  9 14  1  0
 13 10  1  0
 10 11  1  0
  9 12  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 20  1  0
 19 13  2  0
 15 17  1  0
 16 18  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 19  1  0
 23 24  2  0
 21 25  1  6
 26 25  1  0
 27 26  1  0
 25 27  1  0
  1 28  1  0
  2 29  1  0
 22 30  1  0
 31 30  1  0
 32 31  1  0
 30 32  1  0
M  END

Associated Targets(non-human)

Plasma (810 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
pol Human immunodeficiency virus type 1 integrase (9041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 457.89Molecular Weight (Monoisotopic): 457.1205AlogP: 3.07#Rotatable Bonds: 4
Polar Surface Area: 82.85Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 8.08CX Basic pKa: 0.26CX LogP: 1.86CX LogD: 1.78
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.76Np Likeness Score: -0.80

References

1. Schreier JD, Embrey MW, Raheem IT, Barbe G, Campeau LC, Dubost D, McCabe Dunn J, Grobler J, Hartingh TJ, Hazuda DJ, Klein D, Miller MD, Moore KP, Nguyen N, Pajkovic N, Powell DA, Rada V, Sanders JM, Sisko J, Steele TG, Wai J, Walji A, Xu M, Coleman PJ..  (2017)  Discovery and optimization of 2-pyridinone aminal integrase strand transfer inhibitors for the treatment of HIV.,  27  (9): [PMID:28285916] [10.1016/j.bmcl.2017.02.039]

Source